$RYDE
Ryde Group Ltd

2023 Q4 Form 20-F Financial Statement

#000149315224016793 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $8.667M $6.569M $8.825M
YoY Change -1.79% -25.56%
Cost Of Revenue $6.813M $6.813M $7.534M
YoY Change -9.57% -9.57%
Gross Profit $1.854M $1.854M $1.291M
YoY Change 43.61% 43.61%
Gross Profit Margin 21.39% 28.22% 14.63%
Selling, General & Admin $12.71M $12.71M $4.746M
YoY Change 167.7% 167.7%
% of Gross Profit 685.28% 685.28% 367.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $221.0K $47.00K $171.0K
YoY Change 29.24% -84.39%
% of Gross Profit 11.92% 2.54% 13.25%
Operating Expenses $13.11M $13.11M $5.047M
YoY Change 159.7% 159.7%
Operating Profit -$11.25M -$11.25M -$3.756M
YoY Change 199.6% 199.6%
Interest Expense -$446.0K $130.0K -$198.0K
YoY Change 125.25% -165.66%
% of Operating Profit
Other Income/Expense, Net -$506.0K $3.251M -$1.006M
YoY Change -49.7% -423.16%
Pretax Income -$12.87M -$9.755M -$4.960M
YoY Change 159.46% 96.67%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.83M -$9.723M -$4.923M
YoY Change 160.55% 97.5%
Net Earnings / Revenue -148.0% -148.01% -55.78%
Basic Earnings Per Share -$0.75
Diluted Earnings Per Share -$0.67 -$0.75 -$0.26
COMMON SHARES
Basic Shares Outstanding 13.01M shares
Diluted Shares Outstanding 13.01M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.694M $1.694M
YoY Change -43.66%
Cash & Equivalents $1.284M $1.694M $3.007M
Short-Term Investments
Other Short-Term Assets $2.566M $2.566M
YoY Change 387.83%
Inventory
Prepaid Expenses $91.00K $100.0K
Receivables $30.00K $30.00K
Other Receivables $173.0K $173.0K
Total Short-Term Assets $3.383M $4.463M $3.767M
YoY Change -10.19% 18.48%
LONG-TERM ASSETS
Property, Plant & Equipment $46.00K $61.00K $24.00K
YoY Change 91.67% 154.17%
Goodwill
YoY Change
Intangibles $510.0K $532.0K
YoY Change -4.14%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $556.0K $734.0K $556.0K
YoY Change 0.0% 32.01%
TOTAL ASSETS
Total Short-Term Assets $3.383M $4.463M $3.767M
Total Long-Term Assets $556.0K $734.0K $556.0K
Total Assets $3.939M $5.197M $4.323M
YoY Change -8.88% 20.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.141M $5.463M $3.401M
YoY Change 21.76% 60.63%
Accrued Expenses $1.971M $1.971M
YoY Change 138.33%
Deferred Revenue
YoY Change
Short-Term Debt $2.850M $2.850M
YoY Change
Long-Term Debt Due $2.303M $2.303M
YoY Change
Total Short-Term Liabilities $9.541M $12.59M $4.228M
YoY Change 125.66% 197.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $24.00K $0.00 $5.094M
YoY Change -99.53% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.541M $12.59M $4.228M
Total Long-Term Liabilities $24.00K $0.00 $5.094M
Total Liabilities $9.565M $12.54M $9.322M
YoY Change 2.61% 35.06%
SHAREHOLDERS EQUITY
Retained Earnings -$19.63M -$13.07M
YoY Change 50.21%
Common Stock $3.000K $3.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.566M -$7.343M -$4.962M
YoY Change
Total Liabilities & Shareholders Equity $3.939M $5.197M $4.323M
YoY Change -8.88% 20.22%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$12.83M -$9.723M -$4.923M
YoY Change 160.55% 97.5%
Depreciation, Depletion And Amortization $221.0K $47.00K $171.0K
YoY Change 29.24% -84.39%
Cash From Operating Activities $909.0K -$1.223M -$1.517M
YoY Change -159.92% -68.16%
INVESTING ACTIVITIES
Capital Expenditures $233.0K $2.000K $234.0K
YoY Change -0.43% -99.59%
Acquisitions
YoY Change
Other Investing Activities $0.00 $63.00K
YoY Change
Cash From Investing Activities -$233.0K -$319.0K -$234.0K
YoY Change -0.43% -33.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.279M $547.0K 0.000
YoY Change -88.36%
NET CHANGE
Cash From Operating Activities 909.0K -$1.223M -1.517M
Cash From Investing Activities -233.0K -$319.0K -234.0K
Cash From Financing Activities -1.279M $547.0K 0.000
Net Change In Cash -603.0K -$995.0K -1.751M
YoY Change -65.56% -363.93%
FREE CASH FLOW
Cash From Operating Activities $909.0K -$1.223M -$1.517M
Capital Expenditures $233.0K $2.000K $234.0K
Free Cash Flow $676.0K -$1.225M -$1.751M
YoY Change -138.61% -71.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001971115
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
CY2022Q4 us-gaap Goodwill
Goodwill
CY2023Q4 us-gaap Goodwill
Goodwill
CY2023Q4 us-gaap Goodwill
Goodwill
usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
CY2021 RYDE Net Effect Of Exchange Rates Changes
NetEffectOfExchangeRatesChanges
CY2022 RYDE Net Effect Of Exchange Rates Changes
NetEffectOfExchangeRatesChanges
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
CY2023 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
CY2021 RYDE Payment For Deferred Initial Public Offering Costs
PaymentForDeferredInitialPublicOfferingCosts
CY2022 RYDE Payment For Deferred Initial Public Offering Costs
PaymentForDeferredInitialPublicOfferingCosts
CY2021 us-gaap Interest Paid Net
InterestPaidNet
CY2022 us-gaap Interest Paid Net
InterestPaidNet
CY2023 us-gaap Interest Paid Net
InterestPaidNet
CY2023 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021 RYDE Noncash Transactions From Acquisition Of Subsidiaries
NoncashTransactionsFromAcquisitionOfSubsidiaries
CY2022 RYDE Noncash Transactions From Acquisition Of Subsidiaries
NoncashTransactionsFromAcquisitionOfSubsidiaries
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P2Y3M
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
CY2022Q4 us-gaap Goodwill
Goodwill
CY2023Q4 us-gaap Goodwill
Goodwill
CY2023Q4 us-gaap Goodwill
Goodwill
usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityCurrent
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
shares
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41950
CY2023 dei Entity Registrant Name
EntityRegistrantName
Ryde Group Ltd
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Duo Tower
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
3 Fraser Street
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
#08-21
CY2023 dei Entity Address Country
EntityAddressCountry
SG
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
189352
CY2023 dei Security12b Title
Security12bTitle
Class A Ordinary Shares, par value S$0.0002
CY2023 dei Trading Symbol
TradingSymbol
RYDE
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
6651
CY2023 dei Auditor Name
AuditorName
Kreit & Chiu CPA LLP
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3007000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1694000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1284000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
70000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
30000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
23000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
690000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
660000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500000 usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2079000
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1576000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3767000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4463000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3383000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
532000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
673000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
510000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
556000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
734000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
556000 usd
CY2022Q4 us-gaap Assets
Assets
4323000
CY2023Q4 us-gaap Assets
Assets
5197000
CY2023Q4 us-gaap Assets
Assets
3939000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3401000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5463000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4141000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
827000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1922000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1457000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2303000
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1746000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2850000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4228000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12587000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9541000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5094000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
32000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5094000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
32000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
24000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9322000
CY2023Q4 us-gaap Liabilities
Liabilities
12619000
CY2023Q4 us-gaap Liabilities
Liabilities
9565000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8101000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18663000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14146000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13066000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25893000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19626000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-117000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-89000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4962000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-7343000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5566000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-37000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-79000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-60000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4999000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7422000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5626000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4323000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5197000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3939000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6195000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8825000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8667000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6569000 usd
CY2021 us-gaap Other Income
OtherIncome
440000
CY2022 us-gaap Other Income
OtherIncome
289000
CY2023 us-gaap Other Income
OtherIncome
89000
CY2023 us-gaap Other Income
OtherIncome
67000 usd
CY2021 RYDE Drivers And Riders Cost And Related Expenses
DriversAndRidersCostAndRelatedExpenses
4220000
CY2022 RYDE Drivers And Riders Cost And Related Expenses
DriversAndRidersCostAndRelatedExpenses
7534000
CY2023 RYDE Drivers And Riders Cost And Related Expenses
DriversAndRidersCostAndRelatedExpenses
6813000
CY2023 RYDE Drivers And Riders Cost And Related Expenses
DriversAndRidersCostAndRelatedExpenses
5164000 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1473000
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2046000
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2052000
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1555000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
273000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
301000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
402000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
305000 usd
CY2021 RYDE Finance Costs
FinanceCosts
118000
CY2022 RYDE Finance Costs
FinanceCosts
198000
CY2023 RYDE Finance Costs
FinanceCosts
446000
CY2023 RYDE Finance Costs
FinanceCosts
338000 usd
CY2021 us-gaap Other Expenses
OtherExpenses
1791000
CY2022 us-gaap Other Expenses
OtherExpenses
3995000
CY2023 us-gaap Other Expenses
OtherExpenses
4289000
CY2023 us-gaap Other Expenses
OtherExpenses
3251000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
664000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
503000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6959000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5275000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1240000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4960000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12869000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9755000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1240000
CY2022 us-gaap Profit Loss
ProfitLoss
-4960000
CY2023 us-gaap Profit Loss
ProfitLoss
-12869000
CY2023 us-gaap Profit Loss
ProfitLoss
-9755000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-117000
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-89000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1240000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4960000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12986000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9844000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1231000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-4923000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-12827000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-9723000 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
37000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
42000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
32000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-1240000
CY2022 us-gaap Profit Loss
ProfitLoss
-4960000
CY2023 us-gaap Profit Loss
ProfitLoss
-12869000
CY2023 us-gaap Profit Loss
ProfitLoss
-9755000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1231000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4923000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12944000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9812000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
9000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
37000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
42000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
32000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1240000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4960000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12986000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9844000 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11702000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11702000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11702000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11702000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13007000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13007000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13007000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13007000 shares
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
966000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1240000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
118000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-156000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4960000
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
117000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4999000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4999000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12986000
CY2023 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3481000
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7082000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7422000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5626000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5626000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2349000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2349000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
118000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
117000
CY2021 us-gaap Profit Loss
ProfitLoss
-1240000
CY2022 us-gaap Profit Loss
ProfitLoss
-4960000
CY2023 us-gaap Profit Loss
ProfitLoss
-12869000
CY2023 us-gaap Profit Loss
ProfitLoss
-9755000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
265000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
340000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
258000 usd
CY2021 us-gaap Depreciation
Depreciation
8000
CY2022 us-gaap Depreciation
Depreciation
14000
CY2023 us-gaap Depreciation
Depreciation
62000
CY2023 us-gaap Depreciation
Depreciation
47000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1000
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
355000
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
269000 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
91000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
69000 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
664000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
503000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6959000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5275000 usd
CY2023 RYDE Net Effect Of Exchange Rates Changes
NetEffectOfExchangeRatesChanges
-5000
CY2023 RYDE Net Effect Of Exchange Rates Changes
NetEffectOfExchangeRatesChanges
-4000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
59000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-52000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
302000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-107000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-81000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
860000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
539000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1895000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1436000 usd
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
307000
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
354000
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
727000
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
551000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-112000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3841000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1612000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1223000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
303000
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
467000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
482000
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
365000 usd
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
63000
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
48000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-329000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-482000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-422000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319000 usd
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
500000
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5200000
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2850000
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2160000 usd
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
500000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
50000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
38000 usd
CY2023 RYDE Payment For Deferred Initial Public Offering Costs
PaymentForDeferredInitialPublicOfferingCosts
2079000
CY2023 RYDE Payment For Deferred Initial Public Offering Costs
PaymentForDeferredInitialPublicOfferingCosts
1575000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4700000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
721000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
547000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
59000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
377000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1313000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-995000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2571000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2630000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3007000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2279000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2630000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3007000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1694000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1284000 usd
CY2023 RYDE Noncash Transactions From Acquisition Of Subsidiaries
NoncashTransactionsFromAcquisitionOfSubsidiaries
600000
CY2023 RYDE Noncash Transactions From Acquisition Of Subsidiaries
NoncashTransactionsFromAcquisitionOfSubsidiaries
455000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each Class A Ordinary Share shall be entitled to one vote and each Class B Ordinary Share shall be entitled to 10 votes on all matters subject to the vote at general meetings of our Company.
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1612000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1223000 usd
CY2023Q4 RYDE Working Capital
WorkingCapital
-8124000
CY2023Q4 RYDE Working Capital
WorkingCapital
-6158000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1694000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1284000 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_zEtv5jHXhBR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zSUk1elwhK9l">Use of estimates</span> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Significant accounting estimates reflected in the Company’s consolidated financial statements include, but are not limited to, impairment of long-lived assets, and allowance for credit losses on receivables, provision for expired credit. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Foreign Currency Transactions Description
ForeignCurrencyTransactionsDescription
SGD1.00 = USD0.7580
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
690000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
660000
CY2023 RYDE Schedule Of Property And Equipment Estimated Useful Life
ScheduleOfPropertyAndEquipmentEstimatedUsefulLife
<p id="xdx_890_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLife_zeNwayvkiEHj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are stated at cost less accumulated depreciation and impairment if applicable. The Company computes depreciation using the straight-line method over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_z42rwQDpn3jj">Schedule of property and equipment estimated useful life</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zOVb0q0Y96kk">3 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBnaOOeFWl18">3 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renovations </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RenovationsMember_z48rG6mVevu6">3 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease right-of-use assets</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--OperatingLeaseRightOfUseAssetsMember_zzF5UTVqIMOd">2 years</span></span></td></tr> </table>
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
664000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zOmQAq8fABF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_869_zplpGnnShGg6">Concentrations and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of accounts receivable. The Company has designed their credit policies with an objective to minimize their exposure to credit risk. The Company’s accounts receivable are short term in nature and the associated risk is minimal. The Company conducts credit evaluations on its clients and generally does not require collateral or other security. The Company periodically evaluates the creditworthiness of the existing clients in determining the allowance for credit losses primarily based upon the age of the receivables and factors surrounding the credit risk of specific clients. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2023 and 2022, the Company’s assets were located in Singapore and the Company’s revenue was principally derived in Singapore.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RYDE GROUP LTD</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2    </b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary of significant accounting policies (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023 us-gaap Pension Contributions
PensionContributions
211000
CY2023 us-gaap Pension Contributions
PensionContributions
160000 usd
CY2022 us-gaap Pension Contributions
PensionContributions
229000
CY2021 us-gaap Pension Contributions
PensionContributions
162000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
173000
CY2023Q4 us-gaap Other Receivables
OtherReceivables
131000 usd
CY2022Q4 RYDE Provision For Expired Credits
ProvisionForExpiredCredits
161000
CY2023Q4 RYDE Provision For Expired Credits
ProvisionForExpiredCredits
158000
CY2023Q4 RYDE Provision For Expired Credits
ProvisionForExpiredCredits
120000 usd
CY2023 us-gaap Salaries And Wages
SalariesAndWages
4000
CY2023 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2022 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
265000
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
209000
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
158000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
100000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
120000
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
91000 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
164000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
500000 usd
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
2079000
CY2023Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
1576000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
178000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
135000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
117000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46000 usd
CY2023 us-gaap Depreciation
Depreciation
62000
CY2023 us-gaap Depreciation
Depreciation
47000 usd
CY2022 us-gaap Depreciation
Depreciation
14000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2663000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3145000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2384000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2131000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2472000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1874000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
532000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
673000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
510000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
340000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
258000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
287000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
360000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
307000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
664000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
491000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
664000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
491000 usd
CY2023Q1 us-gaap Shares Acquired Weighted Average Discount To Net Assets Percentage
SharesAcquiredWeightedAverageDiscountToNetAssetsPercentage
0.25 pure
CY2023 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
600000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
664000
CY2021 us-gaap Interest Expense
InterestExpense
1000
CY2022 us-gaap Interest Expense
InterestExpense
5000
CY2023 us-gaap Interest Expense
InterestExpense
171000
CY2023 us-gaap Interest Expense
InterestExpense
130000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2850000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
106000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11000 usd
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
5094000
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
2303000
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
1746000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2303000
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1746000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5094000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2850000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2160000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
49000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
37000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
50000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
50000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
49000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
49000
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1240000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4960000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12869000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9755000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-211000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-843000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-963000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-730000 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
47000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
51000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
181000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
137000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-11000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-33000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-7000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-5000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
179000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
828000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
778000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
590000 usd
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-4000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-3000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
11000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
8000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1938000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2635000
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1997000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1938000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2635000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1997000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
32000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
24000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6195000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8825000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8667000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6569000 usd
CY2021 RYDE Government Grants
GovernmentGrants
417000
CY2022 RYDE Government Grants
GovernmentGrants
233000
CY2023 RYDE Government Grants
GovernmentGrants
41000
CY2023 RYDE Government Grants
GovernmentGrants
31000 usd
CY2021 us-gaap Other Operating Income
OtherOperatingIncome
23000
CY2022 us-gaap Other Operating Income
OtherOperatingIncome
56000
CY2023 us-gaap Other Operating Income
OtherOperatingIncome
48000
CY2023 us-gaap Other Operating Income
OtherOperatingIncome
36000 usd
CY2021 us-gaap Other Income
OtherIncome
440000
CY2022 us-gaap Other Income
OtherIncome
289000
CY2023 us-gaap Other Income
OtherIncome
89000
CY2023 us-gaap Other Income
OtherIncome
67000 usd
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1006000
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1124000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1230000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
932000 usd
CY2021 us-gaap Legal Fees
LegalFees
392000
CY2022 us-gaap Legal Fees
LegalFees
437000
CY2023 us-gaap Legal Fees
LegalFees
496000
CY2023 us-gaap Legal Fees
LegalFees
376000 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
266000
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1948000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
2441000
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1850000 usd
CY2021 RYDE Rental Expense
RentalExpense
64000
CY2022 RYDE Rental Expense
RentalExpense
315000
CY2023 RYDE Rental Expense
RentalExpense
23000
CY2023 RYDE Rental Expense
RentalExpense
17000 usd
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
63000
CY2022 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
171000
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
99000
CY2023 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
76000 usd
CY2021 us-gaap Other Expenses
OtherExpenses
1791000
CY2022 us-gaap Other Expenses
OtherExpenses
3995000
CY2023 us-gaap Other Expenses
OtherExpenses
4289000
CY2023 us-gaap Other Expenses
OtherExpenses
3251000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6959000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
5275000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5470000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4146000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1240000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4960000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12986000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9844000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
9000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
37000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
42000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
32000 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1231000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4923000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12944000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9812000 usd
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11702000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11702000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13007000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13007000 shares
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1125000 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
68000 shares

Files In Submission

Name View Source Status
0001493152-24-016793-index-headers.html Edgar Link pending
0001493152-24-016793-index.html Edgar Link pending
0001493152-24-016793.txt Edgar Link pending
0001493152-24-016793-xbrl.zip Edgar Link pending
ex11-2.htm Edgar Link pending
ex12-1.htm Edgar Link pending
ex12-2.htm Edgar Link pending
ex13-1.htm Edgar Link pending
ex13-2.htm Edgar Link pending
ex15-1.htm Edgar Link pending
ex15-1_001.jpg Edgar Link pending
ex15-2.htm Edgar Link pending
ex15-2_001.jpg Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form20-f.htm Edgar Link pending
form20-f_001.jpg Edgar Link pending
form20-f_002.jpg Edgar Link pending
form20-f_003.jpg Edgar Link pending
form20-f_004.jpg Edgar Link pending
form20-f_005.jpg Edgar Link pending
form20-f_006.jpg Edgar Link pending
form20-f_007.jpg Edgar Link pending
form20-f_008.jpg Edgar Link pending
form20-f_009.jpg Edgar Link pending
form20-f_010.jpg Edgar Link pending
form20-f_011.jpg Edgar Link pending
form20-f_012.jpg Edgar Link pending
form20-f_013.jpg Edgar Link pending
form20-f_014.jpg Edgar Link pending
form20-f_015.jpg Edgar Link pending
form20-f_016.jpg Edgar Link pending
form20-f_017.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
form20-f_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
ryde-20231231.xsd Edgar Link pending
Show.js Edgar Link pending
ryde-20231231_def.xml Edgar Link unprocessable
ryde-20231231_lab.xml Edgar Link unprocessable
ryde-20231231_pre.xml Edgar Link unprocessable
ryde-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable